http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014521641-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate | 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014521641-A |
| titleOfInvention | Homoarginine prodrugs and / or conjugates of amphetamine and other stimulants and processes for making and using the same |
| abstract | Homoarginine amphetamine prodrug and / or conjugate compositions, salts thereof, or combinations thereof that can reduce or prevent amphetamine side effects in human subjects, and methods for reducing or preventing amphetamine side effects in human subjects Is disclosed. The present technology relates to improved dosage forms of homoarginine amphetamine prodrugs and / or conjugates that reduce or prevent amphetamine side effects in human subjects. In addition, the techniques described herein also generally relate to methods for reducing or preventing the side effects of amphetamine in humans. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7263350-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021504324-A |
| priorityDate | 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.